Teriparatide biosimilar (Shanghai United Cell ）
特立帕肽生物类似药（上海联合赛尔）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameTeriparatide biosimilar (Shanghai United Cell ）
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2017/03/22
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai United Cell Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai United Cell Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A